Drug General Information
Drug ID
D01LWE
Drug Name
EGFRvIII CAR T cells
Drug Type
CAR T Cell Therapy
Indication Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] Phase 1 [1]
Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] Phase 1 [1]
Company
Gary Archer Ph.D.
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
References
REF 1 ClinicalTrials.gov (NCT02664363) EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.